Find information on thousands of medical conditions and prescription drugs.

Cefaclor

Cefaclor (brand names Ceclor®, Raniclor®) is a 2nd generation cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy school children in Turkey
From Indian Journal of Medical Research, 11/1/04 by Gazi, Hörü

Background & objectives: Information on oropharyngcal carriage rates of Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes and Moraxella catarrhalis and their resistance pattern in healthy school children in Turkey is lacking. The present study was undertaken to determine the carriage rates and antimicrobial resistance of these bacterial pathogens in such children aged 6-14 yr in Manisa, Turkey.

Methods: A total of 1022 children were included from nine schools selected randomly from 32 schools. Throat swabs were cultured for bacteria which were identified using standard microbiological methods. Antimicrobial susceptibility was determined as per National Committee for Clinical Laboratory Standards guidelines.

Results: Of the 1022 children 240 (23.4%) harboured S. pneumoniae, 162 (15.8%) H. influenzae, 30 (2.9%) S. pyogenes and 82 (8%) M. catarrhalis in their oropharynx. For S. pneumoniae overall 17.9 per cent of the isolates were intermediately and 7 per cent were resistant to penicillin and resistance to erythromycin trimethoprim-sulphamethoxasole (TMP/SMX), and chloramphenicol was 13.7, 9.1 and 1.6 per cent, respectively. Ampicillin resistance observed in 20.9 per cent of H. influenzae isolates was associated with the presence of β-lactamase, except two isolates interpreted as β-lactamase-negative ampicillin resistant strains. Resistance of H. influenzae to TMP/SMX, chloramphenicol, azithromycin, cefaclor and amoxicillin/clavulanic acid was 14.2, 2.4, 1.8, 1.2 and 1.2 per cent, respectively. M.catarrhalis isolates produced β-lactamase in 80.5 per cent of the cases and all were susceptible to macrolides and clavulanic acid/amoxicillin combination; the highest rate of resistance of 17 per cent was for TMP/SMX. One (3.3%) isolate of S. pyogenes was resistant to macrolides tested.

Interpretation & conclusion: Our data shows that upper respiratory tract of about 50 per cent children was colonized with respiratory pathogens. There is a need for surveillance of nasopharyngeal carriage of resistant strains in healthy school children.

Key words Antimicrobial resistance - oropharyngeal carriage - school children

The upper respiratory tract of healthy children is frequently colonized with Streptococcuspneumoniae, Haemophilus influenzae, and Moraxella catarrhalis1,2. This nasopharyngeal colonization is a prerequisite for the development of sinusitis, otitis media or more serious infections3,4. Emergence of resistant bacteria such as β-lactamase producing M. catarrhalis and H. influenzae, penicillin resistant S. pneumoniae and macrolide resistant S. pyogenes, has complicated the empirical therapy of these infections in several countries5.

In general, the prevalence of carriage of these pathogenic bacteria in healthy individuals decreases with age4,6. For this reason, epidemiologic studies on the nasopharyngeal carriage of these pathogens have been performed on children under 6 yr of age7,8. There is lack of information on the carriage rates and resistance patterns of these pathogens in Turkish school children. As surveillance of nasopharyngeal carriage of resistant strains is important for initiating adequate empirical antimicrobial therapy, the present study was carried out to determine the carriage rates and antimicrobial resistance patterns of S. pneumoniae, H. influenzae, S. pyogenes and M. catarrhalis isolated from healthy school children in Manisa, Turkey.

Material & Methods

A cross sectional study was conducted in children 6-14 yr of age from November 2002 to January 2003. Relevant information on the study population was obtained from the Bureau of Statistics of the Provincial Education Administration of Manisa city, west Turkey. Information revealed that there were 32 schools in the Manisa city center with a total of 32,244 students enrolled. We stratified the schools into 3 strata accoring to the average socio-economic status, i.e., low, moderate and high. Three schools were randomly selected from each stratum. The sample size was estimated as 1000 students with a confidence level of 95 per cent, prevalance of carriers of pathogens=30 per cent, s=0.03^sup 9^. The number of students in selected schools was 12,475. Each school had eight grades with approximately 40 students in each class. Equal number of students was chosen randomly from each grade and the number of students chosen from each school was proportional to the student population of each school. As a result a total of 1,022 children were included in the study. Informed consents from the parents, and approval from the ethical committee of the institution have been obtained prior to the commencement of the study. Persona] information about those participated in the study was obtained using standardized questionnaires for sociodemographic variables. All children underwent a physical examination regarding upper respiratory tract infection. Children with no signs of respiratory infection and history of receiving antibiotic treatment within the past 2 wk were included in the study.

Throat swabs taken from tonsils and anterior pillars of the oropharynx were immediately introduced in Stuart transport medium (Oxoid Limited, Hampshire, England) and sent to the laboratory within 2 h of collection. Specimens were seeded on sheep blood agar (Oxoid Limited, Hampshire, England) for isolation of S. pneumoniae and S. pyogenes, and on chocolate agar prepared by adding sheep blood to an enriched agar base medium (Oxoid Limited, Hampshire, England) at 80°C for M catharralis and H. influenzas. After 24-48 h incubation in a CO2 enriched atmosphere at 37°C, plates were inspected for growth of bacteria. All isolates were identified by the standard microbiological methods10 and were confirmed as S. pneumoniae, H.influenzae, S. pyogenes and M. catarrhalis on the basis of commercial kits (BBL GP ID; Crystal N/H ID, Becton Dickinson and Co., Sparks, MD, USA). The capsular antigenic typing of H. influenzae was done by slide co-agglutination with commercial antisera (Difco, Detroit, MI, USA).

Antimicrobial susceptibility by the disk diffusion method was performed according to the National Committee for Clinical Laboratory Standards (NCCLS) guidelines". The following antibiotics were used: azithromycin (15 µg) for all 4 bacteria; erythromycin (15 µg) for all except H. influenzae; trimethoprim-sulphamethoxasole (1.25/23.75 µg) and chloramphenicol (30 µg) for all except S. pyogenes; amoxicillin/clavulanic acid (20/10 µg) for H. influenzae and M. catarrhalis; ampicillin (10 µg) for S. pyogenes and H. influenzae; oxacillin (1 µg) for S. pneumoniae; and cefactor (30 µg) for H. influenzae. Minimum inhibitory concentrations (MIC) of penicillin against S. pneumoniae isolates were determined by E test (AB Biodisk, Solna, Sweden) with an inoculum recommended by NCCLS for the disk diffusion method". Susceptibility to penicillin was categorized as susceptible if the MIC was 1.0 µg/ml. The susceptibility tests were performed on Mueller-Hinton agar (Oxoid Limited, Hampshire, England) with 5 per cent sheep blood for S. pneumoniae and S. pyogenes, on Mueller-Hinton agar for M. catarrhalis, and on Haemophilus Test Medium (Oxoid Limited, Hampshire, England) for H. influenzae strains. All isolates of H. influenzae and M. catarrhalis were examined for production of beta-lactamase with a nitrosefin-based test (Oxoid Limited, Hampshire, England). S. pneumoniae ATCC 49619 and H. influenzae ATCC 49247 (Oxoid Limited, Hampshire, England) were used as quality control organisms for susceptibility tests".

A statistical package SPSS10.0 (SPSS incorporated, Chicago) was used for all analysis. A chi square test was used for comparison of categorical variables. A P value of

Results

Of the total 1022 children, S. pneumoniae, H. influenzae, S. pyogenes and M. catarrhalis were detected in 240 (23.4%), 162 (15.8%), 30 (2.9%) and 82 (8%) children, respectively. Of the 162 isolates of H. influenzae, 8 (4.9%) belonged to serotype b. No statistically significant difference was found between the socio-economic status and the carriage rate.

Of the 240 S. pneumoniae isolates investigated, 60 (25%) were found to be resistant to penicillin. Seventeen (7%) isolates were penicillin resistant (MIC≥1 µg/ml) and 43 (17.9%) were intermediately resistant (0.1 ≤ MIC ≤ 1 µg/ml). The MICs did not exceed 2 µg/ml for any of the isolates tested. Second to penicillin, the highest rate of resistance was against erythromycin (13.7%), followed by TMP/SMX (9.1%). Resistance to azithromycin was observed in 33 isolates, which were also resistant to erythromycin (13.7%). Resistance to chloramphenicol occurred in 1.6 per cent of the isolates. Among the 60 isolates that had intermediate or resistance to penicillin, 23 (38.3%) were also resistant to erythromycin and 16 (26.6%) to TMP/SMX. One isolate was fully resistant to penicillin, erythromycin, TMP/SXT and chloramphenicol.

Ampicillin resistance observed in 34 (20.9%) of 162 H. influenzas isolates was associated with the presence of beta-lactamase (19.7%), except in two which did not react with nitrocefin and were identified as β-lactamase negative ampicillin resistant (BLNAR) strains. These 2 (1.2%) isolates were also resistant to cefaclor and clavulanic acid/amoxicillin combination. Of the 34 isolates resistant to ampicillin, 8 (23.5%) were also resistant to TMP/SMX, and 1 (2.9%) to chloramphenicol. Nevertheless all these isolates were susceptible to azithromycin (Table).

Of the 82 M. catarrhalis isolates, 66 (80.5%) were β-lactamase-positive. As there is no breakpoint given for antimicrobials in the NCCLS table that cover Moraxella, results were interpreted according to the criteria for non-fastidious bacteria12. According to the breakpoints for Slaphylococcus spp, all the isolates were susceptible to amoxicillin/clavulanic acid, erythromycin and azithromycin but 14 (17%) isolates were resistant to TMP/SMX and 2 (2.4%) to chloramphenicol.

None of the 30 S. pyogenes isolates tested were resistant to ampicillin, but only one isolate showed crossresistance to erythromycin and azithromycin (3.3%).

Discussion

Discussion

We found that the upper respiratory tract of about 50 per cent of 6-14 yr old children was colonized with potential respiratory pathogens. Similar colonization rates for S. pneumoniae, H. influenzae, and M. catharralis in comparable age group were found in some other studies6,13,14.

Penicillin resistant S. pneumoniae isolates from asymptomatic school children accounted for 25 per cent of the 240 isolates investigated in this study. Forty three isolates (17.9%) were intermediately resistant. Although 17 strains (7%) were resistant, surprisingly, the MICs did not exceed 2 mg/ml for any of isolates tested. In our country, comprehensive epidemiological studies on the carriage rate of S. pneumoniae and its antibiotic resistance in prepubertal ages are not available. To the best of our knowledge, majority of the studies15,16 deals with antibiotic resistance of the strains isolated from chlildren and adults with clinical diseases. In a multicentre study conducted by Gür et al17, including 283 S. pneumoniae isolates from adults and children with clinical diseases, intermediate penicillin resistance was found to be 25.8 per cent and high resistance as 3.9 per cent. Sener et al18 found intermediate penicillin resistance to be 39.9 per cent and high resistance to be 3.5 per cent with the agar dilution method on 143 S. pneumoniae isolates from paediatric patients in 1993-96. These resistance rates were less than those calculated in recent studies carried out in Far East where 50-80 per cent of isolates were found to be highly resistant to penicillin19. Strains with reduced susceptibility to penicillin are usually cross-resistant to other antibiotics19. Previous studies from our country17,18 showed that the predominant antibiotic resistance pattern among pneumococci is penicillin-macrolides resistance. Similarly we found that 38.3 per cent of penicillin resistant isolates were also resistant to erythromycin and azithromycin. Resistance to erythromycin probably resulted from the frequent use of macrolides for the empirical treatment of upper respiratory tract infections in children in our country.

In the present study, 34 of the 162 H. influenzae isolates had resistance to ampicillin (20.9%). The incidence of ß-lactamase producing isolates (19.7%) was similar to that previously reported in other studies of H. influenzae in Europe20. In the USA, the frequency of ß-lactamase production in H. influenzae has been reported to be as high as 31.1 per cent21. The BLNAR isolates were also observed in our study, but have rarely been mentioned in reports from our country17. In Turkish children, Yagci et al22 reported that the rate of ß-Iactamase production was 1-6.1 per cent and that BLNAR had not been observed. Another multicenter study17 reported 7 per cent β-lactamase production and 3.3 per cent of BLNAR in 272 H. influenzae strains mostly isolated from patients with respiratory tract infection. Our isolates depicted a low resistance to chloramphnenicol and azithromycin but more resistance to TMP/SMX. These resistance rates are similar to those reported from Turkey17,22.

The production of β-lactamase among M. catarrhalis was frequent and similar to that found in other studies5,21,23. Among other antimicrobial agents, macrolides and amoxicillin/clavulonate were uniformly effective, i.e., all strains were susceptible whereas only 83 per cent were susceptible to TMP/SXT.

Macrolide resistant S. pyogenes isolates are increasing in some parts of the world and 20-30 per cent resistance is being reported in some countries24. The low rate of macrolides resistance in our isolates is quite similar to that recently reported from Turkey25, indicating that macrolide resistant S. pyogenes are rare in our country.

In conclusion, our results showed that nasopharyngeal carriage of potential respiratory pathogens in school children should not be underestimated. For this reason more comprehensive surveillance studies should be performed to obtain correct information about the carriage rate and antimicrobial resistance of these pathogens in Turkish children.

References

1. Peerbooms PG, Engelcn MN, Stokman DA, Benlhcm BH Van, Weert ML, Bruisten SM, et al, Nasopharyngeal carriage of potential bacterial pathogens related to day care attendance, with special reference to the molecular epidemiology of Haemophilus influenzae. J Clin Microbiol 2002; 40 : 2832-6.

2. Principi N, Marchisio P, Schito GC, Mannelli S. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J 1999; 18 : 517-23.

3. Bluestone CD. Ear and mastoid infections. In: Gorbach SL, Bartlett JB, Blacklow NR, editors. Infectious diseases. Philadelphia: WB Saunders; 1998 p. 530-9.

4. Garcia-Rodriguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother 2002; 50 (Suppl S2) : 59-73.

5. Felmingham D, Feldman C, Hryniewicz W, Klugman K, Kohno S, Low DE, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect 2002; 8 (Suppl. 2) : 12-42.

6. Gunnarsson, RK, Holm SE, Soderstrom M. The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. ScandJPrim Health Care 1998; 16.: 13-7.

7. Chiu SS, Ho PL, Chow FK, Yuen YK, Lau YL. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob Agents Chemother 2001; 45 : 2765-70.

8. Berner R, Schumacher RF, Brandis M, Forster J. Colonization and infection with Moraxella catarrhalis in childhood. Ew J Clin Microbiol Infect Dis 1996; 15 : 506-9.

9. Dean AG, Dean JA, Coulombier D, Orendel KA, Smith DG. Burton All, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, Georgia, USA: Centers for Disease Control and Prevention; 1994.

10. Koneman EW, Alien SD, Janda WM, Schreckenberger PC, Winn WC, editors. Color atlas and textbook of diagnostic microbiology, 5th ed. Philadelphia, PA : Lippincott; 1997 p. 491-521.

11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests - sixth edition. Approved standard, document M2-A6. National committee for Clinical Laboratory Standards: Wayne, PA; 1999.

12. Doern GV. Susceptibility tests of non-fastidious bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology, 6th ed. Washington DC: American Society of Micrbiology Press; 1995 p.1342.

13. Ayyildiz A, Aktas AE, Yazgi H. Nasopharyngeal carriage rate of Haemophilus influenzas in children aged 7-12 years in Turkey. Int J Clin Pract. 2003; 57 : 686-8.

14. Borer A, Meirson H, Peled N, Porat N, Dagan R, Fraser D, et al. Antibiotic-resistant pneumococci carried by young children do not appear to disseminate to adult members of a closed community. Clin Infect Dis. 2001; 33 : 436-44.

15. Sahin U, Unlu M, Demirci M, Akkaya A, Turgut E. Penicillin resistance in Streptococcus pneumoniae in Isparta. Respirology 2001; 6 : 23-6.

16. Çiftçi E, Dogru U, Aysev D, Ince E, Güriz H. Nasopharyngeal colonization with penicillin-resistant Streptococcus pneumoniae in Turkish children. Pediatr Int 2000; 42 : 552-6.

17. Gur D, Ozalp M, Sumerkan B, Kaygusuz A, Toreci K, Koksal I, et al. Prevalence of antimicrobial resistance in Haemophilus influenzas, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Int J Antimicrob Agents 2002; 19 : 207-11.

18. Sener B, Giinalp A. Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital. J Antimicrob Chemother 1998; 42 : 381-4.

19. Inoue M, Lee NY, Hong SW, Lee K, Felmingham D. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 2004; 23:44-51.

20. Blosser-Middleton R, Sahm DF, Thornsberry C, Jones ME, Hogan PA, Critchley IA, et al. Antimicrobial susceptibility of 840 clinical isolates of Haemophilis influenzae collected in four European countries in 2000-2001. Clin Microbiol Infect 2003; 9 : 431-6.

21. Thornsberry C, Ogilvie PT, Holley HP Jr, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother 1999; 43 : 2612-23.

22. Yagci A, Ilki A, Akbenlioglu C, Ulgcr N, Inanly S, Soyletir G, et al. Surveillance of Haemophilis influenzae among respiratory tract samples of Turkish children. Int J Antimicrob Agents 2003; 22 : 548-50.

23. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley HP, Rauch A. Prevalance of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemoter 1996; 40 : 2884-6.

24. Canton R, Loza K, Morosini MI, Baquero F. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureiis in the PROTEKT antimicrobial surveillance programme during 1999-2000. J Antimicrob Chemother 2002; 50 (Suppl S1) : 9-24.

25. Çiftçi E, Dogru U, Guriz H, Ayscv D, Ince E. Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish children. Pediatr Int 2002; 44 : 647-51.

Hörü Gazi, Semra Kurutepe, Süheyla Sürücüoglu, Asli Teker & Beril Özbakkaloglu

Department of Microbiology & Clinical Microbiology, Celal Bayar University Faculty of Medicine

Manisa, Turkey

Received December 11, 2003

Reprint requests: Dr Hörü Gazi, Yasam Poliklinigi, Htirriyet cad. No: 142A, Atatürk Mäh, Bornova, Izmir, Turkey

e-mail: horugazi@hotmail.com

Copyright Indian Council of Medical Research Nov 2004
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Cefaclor
Home Contact Resources Exchange Links ebay